Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2012
03/29/2012US20120077810 Inhibitors Of AKT Activity
03/29/2012US20120077809 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077781 Flavin derivatives
03/29/2012US20120077760 Novel salts of sitagliptin
03/29/2012US20120077677 Use of 4-phenylbutyric acid and/or salts thereof for enhancing stress tolerance in plants
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120075273 Indolo[3,2,1-jk]carbazole compound and organic light-emitting device containing the same
03/29/2012US20120074393 Semiconductors based on diketopyrrolopyrroles
03/29/2012CA2812467A1 Atropisomers of pi3k-inhibiting compounds
03/29/2012CA2812378A1 Fused tricyclic compounds as adenosine receptor antagonist
03/29/2012CA2811714A1 Imidazotriazinone compounds
03/29/2012CA2807904A1 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace)
03/29/2012CA2807496A1 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2432784A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
03/28/2012EP2432783A1 Modulators of 5-ht receptors and methods of use thereof
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012EP2432555A1 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
03/28/2012EP2432472A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
03/28/2012EP2432318A1 Bimacrocyclic hcv ns3 protease inhibitors
03/28/2012EP2326649B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS
03/28/2012EP2297148B8 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
03/28/2012EP2183201B1 Process for the resolution of zopiclone and intermediate compounds
03/28/2012EP2178878B1 Tetracyclic compounds for the treatment of hepatitis c
03/28/2012EP1799685B1 Polymorphic forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012CN102395590A Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
03/28/2012CN102395585A Heteroaryls and their use as pi3k inhibitors
03/28/2012CN102391270A Preparation method for tetra-(o-pivaloyl amino phenyl) zinc protoporphyrin isomer compound
03/28/2012CN102391269A Zinc protoporphyrin containing heterocyclic ring as well as synthesis and applications of zinc protoporphyrin containing heterocyclic ring and metal complex of zinc protoporphyrin containing heterocyclic ring
03/28/2012CN102391268A Photobase generator containing alkoxy bicyclic guanidine and preparation method and use thereof
03/28/2012CN102391255A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
03/28/2012CN101928264B Apoptosis promoters
03/27/2012US8143394 Pyrido(3,2-d)pyrimidines useful for treating viral infections
03/27/2012US8143393 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/27/2012US8143375 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
03/27/2012US8143304 (3-amino-1,2,3,4-tetrahydro-9 H-carbazol-9-yl)-acetic acid derivatives
03/27/2012US8143289 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/27/2012US8143275 Use of triazolopyrimidine derivatives as microbicides
03/27/2012US8143272 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/27/2012US8143263 Therapeutic agents
03/27/2012US8143262 7-(3′,4′-Dialkoxyphenyl)[1,2,4]-triazolo[1,5-A]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same
03/27/2012US8143255 Heteroalkyl linked pyrimidine derivatives
03/27/2012US8143251 Triazolotriazines as kinase inhibitors
03/27/2012CA2544193C A2b adenosine receptor antagonists
03/27/2012CA2524898C 6-arylmethyl-substituted pyrazolopyrimidines
03/27/2012CA2496203C Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/22/2012WO2012037155A2 Tyrosine kinase inhibitors
03/22/2012WO2012035934A1 Organic electroluminescent element
03/22/2012WO2012035853A1 Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device
03/22/2012WO2012035549A2 An improved process for the synthesis of beta amino acid derivatives
03/22/2012WO2012035489A1 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
03/22/2012WO2012035158A1 Pyrazine derivatives as enac blockers
03/22/2012WO2012035023A1 Triazine-oxadiazoles
03/22/2012WO2012034954A1 Substituted hexahydropyrrolo [1, 2 - c] imidazolones useful as mdm2 inhibitors
03/22/2012WO2012034526A1 Fused heteroaryls and their uses
03/22/2012WO2012034363A1 Compounds of hedgehog pathway inhibitors, pharmaceutical compositions containing the same and uses thereof
03/22/2012WO2012034267A1 Silafluorene metalloporphyrin- benzene organic semiconductor material and preparing method and uses thereof
03/22/2012WO2012001308A9 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials
03/22/2012US20120071658 PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071636 Risperidone immunoassay
03/22/2012US20120071499 Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones
03/22/2012US20120071490 P70 s6 kinase inhibitors
03/22/2012US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/22/2012US20120071475 Urea derivatives having pi3k-inhibiting activity
03/22/2012US20120071474 Inhibitors of pi3 kinase
03/22/2012US20120071473 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
03/22/2012US20120071469 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
03/22/2012US20120071463 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/22/2012US20120071461 Substituted Benzamide Compounds
03/22/2012US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/22/2012US20120071450 Organic compounds
03/22/2012US20120070409 Tetracyclic fused heterocyclic compound and use thereof as hcv polymerase inhibitor
03/22/2012US20120070377 Compounds and biological materials and uses thereof
03/22/2012US20120068170 Materials for organic electroluminescent devices
03/22/2012US20120068123 Use of phthalocyanine compounds with aryl or hetaryl substituents in organic solar cells
03/22/2012DE102011007727A1 Halbleitende zusammensetzung Semiconducting composition
03/22/2012CA2812081A1 Triazine-oxadiazoles
03/22/2012CA2811076A1 Pyrazine derivatives as enac blockers
03/22/2012CA2810708A1 Fused heteroaryls and their uses
03/21/2012EP2431370A1 Monoacylated 1,2-diaminocycloalkanes
03/21/2012EP2431366A1 New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer
03/21/2012EP2430026A1 Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
03/21/2012EP2430025A1 Sitagliptin synthesis
03/21/2012EP2430024A1 [1,2,4]triazolo [4,3-b]pyridazines as ligands of the androgen receptor
03/21/2012EP2430015A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
03/21/2012EP2430013A1 Heteroaryl compounds as pikk inhibitors
03/21/2012EP2325169A9 Lisofylline analogues and their pharmeacuetical uses
03/21/2012EP1771450B9 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
03/21/2012CN102388051A Inhibitors of HIV replication
03/21/2012CN102388050A N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/21/2012CN102388049A N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/21/2012CN102388048A Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
03/21/2012CN102388047A Novel salts of sitagliptin
03/21/2012CN102388046A Pyrrolopyrrole derivatives, their manufacture and use as semiconductors
03/21/2012CN102388045A Compounds for the treatment of hepatitis c
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 573